APREA THERAPEUTICS INC (APRE)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.79-1.49%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · APRE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||||
| R&D Expenses | — | — | — | — | — | 23.9 | 37.9 | 21.0 |
| Operating Income | (13.2) | (13.2) | (14.3) | (15.5) | (113.4) | (37.4) | — | — |
| Earnings from Continuing Operations | ||||||||
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||
| Net Income | (12.3) | (12.6) | (13.0) | (14.3) | (112.7) | (37.1) | (53.5) | (28.1) |
| Per Share | ||||||||
| Basic EPS | (0.23) | (1.93) | (2.35) | (3.95) | (67.99) | (34.88) | (50.61) | — |
| Diluted EPS | (0.23) | (1.93) | (2.45) | (3.95) | (67.99) | (34.88) | (50.61) | — |
| Basic Weighted Avg Shares | 53.5 | 6.5 | 5.5 | 3.6 | 1.7 | 1.1 | 1.1 | — |
| Diluted Weighted Avg Shares | 53.5 | 6.5 | 5.5 | 3.6 | 1.7 | 1.1 | 1.1 | — |
| Supplemental | ||||||||
| EBITDA | — | (13.2) | (14.3) | (15.5) | (113.4) | (37.4) | — | — |
| EBIT | (13.2) | (13.2) | (14.3) | (15.5) | (113.4) | (37.4) | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.